NCT07210359

Brief Summary

The goal of this clinical trial is to evaluate if regenerative endodontic treatment using two different forms of demineralized dentin matrix (DDM) can effectively treat immature permanent single-rooted teeth compared to treatment using RetroMTA in patients aged 9 to 15 years. The main questions it aims to answer are: Does the use of DDM improve clinical and radiographic outcomes such as root length, dentinal wall thickness, and apex closure? Is DDM a viable bioactive alternative to RetroMTA as a coronal sealing material in regenerative endodontic procedures? Researchers will compare three groups: one using RetroMTA, one using a DDM-TheraCal LC mixture, and one using TDM-Hydrogel, to see if these materials differ in their effects on regenerative outcomes. Participants will: Undergo two treatment visits including canal disinfection, induction of bleeding to form a blood clot scaffold, Receive placement of one of the study materials over the blood clot as a coronal barrier, Have clinical examinations and CBCT imaging at baseline and multiple follow-ups up to 12 months to assess treatment success through signs, symptoms, and radiographic changes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 15, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 29, 2025

Last Update Submit

September 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maturation of root

    root length increase, root width increase, apical formane closes and dentinal bridge formation over regenerated pulp

    year

Secondary Outcomes (1)

  • resolve of apical lesion if present

    1 year

Other Outcomes (1)

  • regain sensibility of pulp

    1 t 2 years

Study Arms (3)

treated hyman dentin matrix hydrogel

ACTIVE COMPARATOR

material used for regenerative dentistry

Procedure: Theracal LC - Demineralized dentin matrix combinationProcedure: Retro Mta

Theracal LC- Demineralized dentina matrix combination

ACTIVE COMPARATOR

material used for regenerative dentistry

Procedure: human treated dentin matrix hydrogelProcedure: Retro Mta

RetroMTA

ACTIVE COMPARATOR

material used for regenerative dentistry

Procedure: human treated dentin matrix hydrogelProcedure: Theracal LC - Demineralized dentin matrix combination

Interventions

material used for regenerative dentistry

Also known as: demineralized dentin matrix
RetroMTATheracal LC- Demineralized dentina matrix combination

material used for regenerative dentistry

RetroMTAtreated hyman dentin matrix hydrogel
Retro MtaPROCEDURE

material used for regenerative dentistry

Theracal LC- Demineralized dentina matrix combinationtreated hyman dentin matrix hydrogel

Eligibility Criteria

Age9 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Systemically healthy patients (i.e., free of any systemic diseases).
  • Patients presenting with immature permanent single-rooted teeth.
  • Age: 9 -15 years.
  • Teeth diagnosed as either vital (asymptomatic irreversible pulpitis or symptomatic irreversible pulpitis and the bleeding didn't stop after 5 minutes application of hemostatic agent) or non-vital pulp.

You may not qualify if:

  • Patients who are allergic to any drugs used in this study or with systemic illness
  • Teeth that are grossly decayed or fractured and require post and core as final restorations
  • Presence of periodontal pockets greater than 4 mm.
  • Radiographical evidence of apical foramen less than 1 mm.
  • Presence of periapical radiolucency exceeding 10 mm.
  • Presence of external or internal root resorption.
  • Patients with a history of major surgeries like cardiac, kidney transplantation, haemodialysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KafrelsheikhU

Kafr ash Shaykh, Kafr Elsheikh, 33511, Egypt

RECRUITING

MeSH Terms

Conditions

Dental Pulp Necrosis

Interventions

Demineralized Dentin Matrix

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hisham Abada, Doctors

    Academic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dina Sarhan, Masters

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer at Endodontic department

Study Record Dates

First Submitted

September 29, 2025

First Posted

October 7, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

September 20, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

October 7, 2025

Record last verified: 2025-09

Locations